End-stage cardiomyopathy because of hereditary hemochromatosis successfully treated with erythrocytapheresis in combination with left ventricular assist device support

E. Rombout-Sestrienkova, N. de Jonge, K. Martinakova, C. Klopping, K.P. van Galen, A. Vink, E.M. Wajon, W.M. Smit, C. van Bree, G.H. Koek

Research output: Contribution to journalEditorialAcademicpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)541-543
Number of pages3
JournalCirculation-Heart Failure
Volume7
Issue number3
DOIs
Publication statusPublished - May 2014

Keywords

  • dilated cardiomiopathy
  • erythrocytapheresis
  • hereditary hemochromatosis
  • left ventricular assist device
  • nonischemic cardiomiopathy
  • IRON-OVERLOAD
  • PHLEBOTOMY

Cite this

Rombout-Sestrienkova, E., de Jonge, N., Martinakova, K., Klopping, C., van Galen, K. P., Vink, A., Wajon, E. M., Smit, W. M., van Bree, C., & Koek, G. H. (2014). End-stage cardiomyopathy because of hereditary hemochromatosis successfully treated with erythrocytapheresis in combination with left ventricular assist device support. Circulation-Heart Failure, 7(3), 541-543. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001198